insights_auto
Why is REGN up ၃.၃၅%?
Dive Deeperchevron_right
REGN:NASDAQ
Regeneron Pharmaceuticals Inc
၇၇၈.၃၆ US$
arrow_upward
+၃.၃၅%(+၂၅.၂၄) 1D
၇၈၂.၅၄ US$
arrow_upward
+၀.၅၄% (+၄.၁၇)bedtimeAfter hours
Closed: အောက် ၁၄, GMT-၄ ၁၆:၀၀:၀၁ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for REGN...
Open
၇၅၈.၁၆ US$
High
၇၈၁.၈၄ US$
Low
၇၅၅.၂၁ US$
Mkt. cap
ဋေ ၈.၀၁ ထ
Avg. vol.
၇.၀၆ သိန်း
Volume
၀.၀၀
Dividend
၀.၄၈%
Quarterly dividend
၀.၉၄ US$
Ex-dividend date
၂၀၂၆ ဩ ၁၈
P/E ratio
၁၉.၂၄
52-wk high
၈၅၉.၃၄ US$
52-wk low
၅၆၄.၀၀ US$
EPS
၄၀.၄၅ US$
Beta
၀.၁၆
Shares outstanding
၁၀.၁၁ ကုဋေ
No. of employees
၂ သောင်း
Open
၇၅၈.၁၆ US$
High
၇၈၁.၈၄ US$
Low
၇၅၅.၂၁ US$
Mkt. cap
ဋေ ၈.၀၁ ထ
Avg. vol.
၇.၀၆ သိန်း
Volume
၀.၀၀
Dividend
၀.၄၈%
Quarterly dividend
၀.၉၄ US$
Ex-dividend date
၂၀၂၆ ဩ ၁၈
P/E ratio
၁၉.၂၄
52-wk high
၈၅၉.၃၄ US$
52-wk low
၅၆၄.၀၀ US$
EPS
၄၀.၄၅ US$
Beta
၀.၁၆
Shares outstanding
၁၀.၁၁ ကုဋေ
No. of employees
၂ သောင်း
News stories
From web sources and news partners
GuruFocus
·
ပြီးခဲ့သည့် ၈ နာရီ
UBS Upgrades Regeneron Pharmaceuticals (REGN) on Next-Gen Dupixent Potential
Yahoo Finance
·
ပြီးခဲ့သည့် ၉ နာရီ
What Could Send Regeneron Stock Higher?
Seeking Alpha
·
ပြီးခဲ့သည့် ၉ နာရီ
Regeneron a new Buy at UBS as Street undervalues Dupixent's future
Kalkine Media
·
ပြီးခဲ့သည့် ၁၀ နာရီ
Regeneron Pharmaceuticals (NASDAQ:REGN): What Changes After Its Latest Company Update?
Profile
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
About Regeneron Pharmaceuticals Inc
CEOLeonard Schleifer
Employees၁.၅၃ သောင်း
Founded၁၉၈၈
HeadquartersTarrytown, နယူးယောက်ပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websiteregeneron.com